NCT06171789 2026-02-25PRO1107 in Patients With Advanced Solid TumorsGenmabPhase 1/2 Terminated33 enrolled
NCT06625515 2026-02-24First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined CancersAccent TherapeuticsPhase 1 Terminated17 enrolled